171 related articles for article (PubMed ID: 21277072)
21. Effect of different antibiotics on biofilm produced by uropathogenic Escherichia coli isolated from children with urinary tract infection.
González MJ; Robino L; Iribarnegaray V; Zunino P; Scavone P
Pathog Dis; 2017 Jun; 75(4):. PubMed ID: 28505288
[TBL] [Abstract][Full Text] [Related]
22. A flow chamber assay for quantitative evaluation of bacterial surface colonization used to investigate the influence of temperature and surface hydrophilicity on the biofilm forming capacity of uropathogenic Escherichia coli.
Andersen TE; Kingshott P; Palarasah Y; Benter M; Alei M; Kolmos HJ
J Microbiol Methods; 2010 May; 81(2):135-40. PubMed ID: 20188127
[TBL] [Abstract][Full Text] [Related]
23. Clofibric and ethacrynic acids prevent experimental pyelonephritis by Escherichia coli in mice.
Balagué CE; de Ruiz CS; Rey R; de Duffard AM; Nader-Macías ME
FEMS Immunol Med Microbiol; 2004 Nov; 42(3):313-9. PubMed ID: 15477045
[TBL] [Abstract][Full Text] [Related]
24. [Uropathogenic Escherichia coli (UPEC) strains in Erzurum].
Ayyildiz A; Balkan R; Babacan M
Mikrobiyol Bul; 1989 Jul; 23(3):197-202. PubMed ID: 2577279
[TBL] [Abstract][Full Text] [Related]
25. FimH antagonists for the oral treatment of urinary tract infections: from design and synthesis to in vitro and in vivo evaluation.
Klein T; Abgottspon D; Wittwer M; Rabbani S; Herold J; Jiang X; Kleeb S; Lüthi C; Scharenberg M; Bezençon J; Gubler E; Pang L; Smiesko M; Cutting B; Schwardt O; Ernst B
J Med Chem; 2010 Dec; 53(24):8627-41. PubMed ID: 21105658
[TBL] [Abstract][Full Text] [Related]
26. [The role of E. coli adhesiveness in the pathogenesis and clinical course of urinary tract infections].
Krzeska I; Ostojska J; Dzierzanowska D
Pol Tyg Lek; 1992 Aug 7-17; 47(31-33):706-9. PubMed ID: 1362812
[TBL] [Abstract][Full Text] [Related]
27. Amaranthus caudatus extract inhibits the invasion of E. coli into uroepithelial cells.
Mohanty S; Zambrana S; Dieulouard S; Kamolvit W; Nilsén V; Gonzales E; Östenson CG; Brauner A
J Ethnopharmacol; 2018 Jun; 220():155-158. PubMed ID: 29621584
[TBL] [Abstract][Full Text] [Related]
28. Low frequency of antibiotic resistance among urine isolates of Escherichia coli in the community, despite a major hospital outbreak with Klebsiella pneumoniae producing CTX-M-15 in Uppsala County.
Lindbäck H; Lindbäck J; Sylvan S; Melhus A
Scand J Infect Dis; 2010 Apr; 42(4):243-8. PubMed ID: 20085420
[TBL] [Abstract][Full Text] [Related]
29. Study on the influence of cranberry extract Żuravit S·O·S(®) on the properties of uropathogenic Escherichia coli strains, their ability to form biofilm and its antioxidant properties.
Wojnicz D; Sycz Z; Walkowski S; Gabrielska J; Aleksandra W; Alicja K; Anna SŁ; Hendrich AB
Phytomedicine; 2012 Apr; 19(6):506-14. PubMed ID: 22306419
[TBL] [Abstract][Full Text] [Related]
30. Sexually transmitted Escherichia coli urethritis and orchiepididymitis.
Dan M; Gottesman T; Schwartz O; Tsivian A; Gophna U; Rokney A
Sex Transm Dis; 2012 Jan; 39(1):16-7. PubMed ID: 22183838
[TBL] [Abstract][Full Text] [Related]
31. [The role of fimbriae of Escherichia coli in urinary tract infections].
Ishikawa S
Hinyokika Kiyo; 1991 Sep; 37(9):953-6. PubMed ID: 1686148
[TBL] [Abstract][Full Text] [Related]
32. Changing prevalence of Escherichia coli with CTX-M-type extended-spectrum beta-lactamases in outpatient urinary E. coli between 2003 and 2008.
Qi C; Pilla V; Yu JH; Reed K
Diagn Microbiol Infect Dis; 2010 May; 67(1):87-91. PubMed ID: 20227224
[TBL] [Abstract][Full Text] [Related]
33. Comparison of the Anti-Adhesion Activity of Three Different Cranberry Extracts on Uropathogenic P-fimbriated Escherichia coli: a Randomized, Double-blind, Placebo Controlled, Ex Vivo, Acute Study.
Howell A; Souza D; Roller M; Fromentin E
Nat Prod Commun; 2015 Jul; 10(7):1215-8. PubMed ID: 26411014
[TBL] [Abstract][Full Text] [Related]
34. Effect of subminimal inhibitory concentrations of gentamicin, penicillin, trimethoprim-sulfamethoxazole on adherence of uropathogenic Escherichia coli strains.
Baskin H; Dogan Y; Hakki BI; Yulug N
J Chemother; 2002 Apr; 14(2):161-5. PubMed ID: 12017371
[TBL] [Abstract][Full Text] [Related]
35. [Prevention and therapy of urinary tract infections after gynecologic and obstetric surgery].
Bellmann O; Werner H; Weissbach L
Gynakologe; 1982 Mar; 15(1):35-44. PubMed ID: 7042490
[No Abstract] [Full Text] [Related]
36. Escherichia coli in urinary tract infections in Sudanese patients.
Erwa HH
Trop Geogr Med; 1972 Jan; 24(1):60-5. PubMed ID: 4551336
[No Abstract] [Full Text] [Related]
37. In vitro biofilm formation by uropathogenic Escherichia coli and their antimicrobial susceptibility pattern.
Ponnusamy P; Natarajan V; Sevanan M
Asian Pac J Trop Med; 2012 Mar; 5(3):210-3. PubMed ID: 22305786
[TBL] [Abstract][Full Text] [Related]
38. Reactive oxygen species and uspA overexpession: an alternative bacterial response toward selection and maintenance of multidrug resistance in clinical isolates of uropathogenic E. coli.
Bandyopadhyay D; Mukherjee M
Eur J Clin Microbiol Infect Dis; 2020 Sep; 39(9):1753-1760. PubMed ID: 32399681
[TBL] [Abstract][Full Text] [Related]
39. [Relation between P-fimbriae and resistance to amoxicillin, carbenicillin and tetracycline in uropathogenic strains of Escherichia coli].
Vranes J; Schönwald S; Zagar Z
Lijec Vjesn; 1994; 116(7-8):178-81. PubMed ID: 7853994
[TBL] [Abstract][Full Text] [Related]
40. Targeting multiple biofilm pathways.
Hett EC; Hung DT
Chem Biol; 2009 Dec; 16(12):1216-8. PubMed ID: 20064430
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
